{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:31:07Z","timestamp":1790667067299,"version":"4.1.0"},"reference-count":135,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.jaut.2016.06.006","type":"journal-article","created":{"date-parts":[[2016,6,25]],"date-time":"2016-06-25T22:21:59Z","timestamp":1466893319000},"page":"27-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"special_numbering":"C","title":["Lupus nephritis: When and how often to biopsy and what does it mean?"],"prefix":"10.1016","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4955-6061","authenticated-orcid":false,"given":"Gabriella","family":"Moroni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Depetri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Ponticelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2016.06.006_bib1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1681\/ASN.V102413","article-title":"Lupus nephritis","volume":"10","author":"Cameron","year":"1999","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.jaut.2016.06.006_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1191\/0961203305lu2055oa","article-title":"Clinical presentation and monitoring of lupus nephritis","volume":"14","author":"Balow","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.006_bib3","series-title":"Kidney Pathology Decennial 1966\u20131975","first-page":"435","article-title":"Lupus nephritis","author":"McCluskey","year":"1975"},{"key":"10.1016\/j.jaut.2016.06.006_bib4","series-title":"Renal Disease: Classification and Atlas of Glomerular Disease","author":"Churg","year":"1982"},{"key":"10.1016\/j.jaut.2016.06.006_bib5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/01.ASN.0000108969.21691.5D","article-title":"The classification of glomerulonephritis in systemic lupus erythematosus revisited","volume":"15","author":"Weening","year":"2004","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.jaut.2016.06.006_bib6","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1523-1755.2004.00443.x","article-title":"The classification of glomerulonephritis in systemic lupus erythematosus revisited","volume":"65","author":"Weening","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.jaut.2016.06.006_bib7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrrheum.2015.159","article-title":"What is damaging the kidney in lupus nephritis?","volume":"12","author":"Davidson","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.006_bib8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.semnephrol.2006.09.005","article-title":"The pathology of lupus nephritis","volume":"27","author":"Schwartz","year":"2007","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.jaut.2016.06.006_bib9","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/0955-0674(91)90045-Z","article-title":"Assembly of macromolecular pores by immune defense systems","volume":"3","author":"Peitsch","year":"1991","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.jaut.2016.06.006_bib10","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1136\/ard.2004.024943","article-title":"AntiC1q antibodies in nephritis: correlation between titers and renal disease activity and positive value in systemic lupus erythematosus","volume":"64","author":"Marto","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.06.006_bib11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000167563","article-title":"The importance of sample size in the interpretation of the renal biopsy","volume":"8","author":"Corwin","year":"1988","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.jaut.2016.06.006_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/019131299281725","article-title":"The value of electron microscopy in the diagnosis and clinical management of lupus nephritis","volume":"23","author":"Herrera","year":"1999","journal-title":"Ultrastruct. Pathol."},{"key":"10.1016\/j.jaut.2016.06.006_bib13","series-title":"Heptinstall\u2019s Pathology of the Kidney","first-page":"541","article-title":"Renal disease in systemic lupus erythematosus, mixed connective tissue disease, Sjogren\u2019s syndrome, and rheumatoid arthritis","author":"D\u2019AgatiV","year":"1998"},{"key":"10.1016\/j.jaut.2016.06.006_bib14","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1053\/j.ajkd.2004.08.027","article-title":"New subcategories of class IV lupus nephritis: are there clinical, histologic, and outcome differences?","volume":"44","author":"Mittal","year":"2004","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jaut.2016.06.006_bib15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/ki.1983.170","article-title":"Pathologic differentiation between lupus and non-lupus membranous glomerulopathy","volume":"24","author":"Jennette","year":"1983","journal-title":"Kidney Int."},{"key":"10.1016\/j.jaut.2016.06.006_bib16","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1046\/j.1523-1755.2001.00730.x","article-title":"Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis","volume":"59","author":"Najafi","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.jaut.2016.06.006_bib17","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1681\/ASN.2011060558","article-title":"Segmental and global subclasses of class IV lupus nephritis have similar renal outcomes","volume":"23","author":"Haring","year":"2012","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.jaut.2016.06.006_bib18","series-title":"Renal Disease: Classification and Atlas of Glomerular Diseases","first-page":"151","article-title":"Lupus nephritis","author":"Churg","year":"1995"},{"key":"10.1016\/j.jaut.2016.06.006_bib19","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1097\/00000478-200608000-00015","article-title":"Interobserver reproducibility and application of the ISN\/RPS classification of lupus nephritis-a UK-wide study","volume":"30","author":"Furness","year":"2006","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.jaut.2016.06.006_bib20","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1681\/ASN.2015040384","article-title":"The revisited classification of GN in SLE at 10 years: time to re-evaluate histopathologic lesions","volume":"26","author":"Wilhelmus","year":"2015","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.jaut.2016.06.006_bib21","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1007\/s00296-011-1986-8","article-title":"ISN\/RPS 2003 class II mesangial proliferative lupus nephritis: a comparison between cases that progressed to class III or IV and cases that did not","volume":"32","author":"Lee","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2016.06.006_bib22","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1191\/0961203305lu2238oa","article-title":"Factors associated with poor outcomes in patients with lupus nephritis","volume":"14","author":"Contreras","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.006_bib23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/0961203313514623","article-title":"Prognosis of proliferative lupus nephritis subsets in the Louvain lupus nephritis inception Cohort","volume":"23","author":"Vandepapeli\u00e8re","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.006_bib24","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.semarthrit.2011.08.002","article-title":"Membranous nephropathy in systemic lupus erythematosus: long-term outcome and prognostic factors of 103 patients","volume":"41","author":"Moroni","year":"2012","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.006_bib25","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/qjmed\/92.4.211","article-title":"The very long-term prognosis and complications of lupus nephritis and its treatment","volume":"92","author":"Bono","year":"1999","journal-title":"QJM"},{"key":"10.1016\/j.jaut.2016.06.006_bib26","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/0961203307083443","article-title":"Long-term outcome of Chinese patients with membranous lupus nephropathy","volume":"17","author":"Sun","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.006_bib27","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1093\/ndt\/gfs122","article-title":"Outcome of patients with membranous lupus nephritis in Cape Town South Africa","volume":"27","author":"Okpechi","year":"2012","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.jaut.2016.06.006_bib28","first-page":"186","article-title":"Lupus membranous glomerulonephritis: different prognostic subgroups obscured by imprecise histologic classifications","volume":"3","author":"Adler","year":"1990","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.jaut.2016.06.006_bib29","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/096120339500400206","article-title":"Prognostic determinants in lupus nephritis: a long-term clinicopathologic study","volume":"4","author":"Donadio","year":"1995","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.006_bib30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1681\/ASN.V72299","article-title":"Long-term outcome in systemic lupus erythematosus membranous glomerulonephritis","volume":"7","author":"Sloan","year":"1996","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.jaut.2016.06.006_bib31","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1053\/ajkd.1998.v31.pm9531186","article-title":"Treatment of membranous lupus nephritis","volume":"31","author":"Moroni","year":"1998","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jaut.2016.06.006_bib32","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0272-6386(12)80885-7","article-title":"Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL)","volume":"18","author":"Banfi","year":"1991","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jaut.2016.06.006_bib33","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1681\/ASN.V481499","article-title":"Renal vascular complications of systemic lupus erythematosus","volume":"4","author":"Appel","year":"1994","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.jaut.2016.06.006_bib34","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/ki.2010.13","article-title":"Tubulointerstitial lesions of patients with lupus nephritis classified by the 2003 International society of Nephrology and renal pathology society system","volume":"77","author":"Yu","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.jaut.2016.06.006_bib35","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0002-9343(83)90338-8","article-title":"Prognostic factors in lupus nephritis. Contributions of renal histological data","volume":"75","author":"Austin","year":"1983","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jaut.2016.06.006_bib36","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/MAJ.0000000000000399","article-title":"Prediction of renal outcomes in patients with crescentic lupus nephritis","volume":"349","author":"Chen","year":"2015","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.jaut.2016.06.006_bib37","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.md.0000091181.93122.55","article-title":"Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients","volume":"82","author":"Cervera","year":"2003","journal-title":"Medicine"},{"key":"10.1016\/j.jaut.2016.06.006_bib38","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/rheumatology\/kev311","article-title":"The frequency and outcome of lupus nephritis: results from an international inception cohort study","volume":"55","author":"Hanly","year":"2016","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2016.06.006_bib39","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11926-016-0571-2","article-title":"Mortality in systemic lupus erythematosus: an updated review","volume":"18","author":"Fors Nieves","year":"2016","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.jaut.2016.06.006_bib40","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/01.ASN.0000102472.37947.14","article-title":"Timing of complications in percutaneous renal biopsy","volume":"15","author":"Whittier","year":"2004","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.jaut.2016.06.006_bib41","first-page":"8121","article-title":"Renal biopsy for medical renal disease: indications and contraindications","volume":"23","author":"Bandari","year":"2016","journal-title":"Can. J. Urol."},{"key":"10.1016\/j.jaut.2016.06.006_bib42","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1001\/archinte.1978.03630340056018","article-title":"Marginal benefit of renal biopsy in systemic lupus erythematosus","volume":"138","author":"Fries","year":"1978","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jaut.2016.06.006_bib43","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0002-9343(82)90812-9","article-title":"Lupus nephritis. Experience with 230 patients in a private practice from 1950 to 1980","volume":"72","author":"Wallace","year":"1982","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jaut.2016.06.006_bib44","doi-asserted-by":"crossref","first-page":"233","DOI":"10.5858\/133.2.233","article-title":"Renal disease in systemic lupus erythematosus with emphasis on classification of lupus glomerulonephritis: advances and implications","volume":"133","author":"Seshan","year":"2009","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.jaut.2016.06.006_bib45","first-page":"70","article-title":"Renal biopsy: a much needed tool in patients with systemic lupus erythematosis","volume":"32","author":"Mahmood","year":"2016","journal-title":"Pak. J. Med. Sci."},{"key":"10.1016\/j.jaut.2016.06.006_bib46","first-page":"332","article-title":"Renal biopsy in lupus patients with low levels of proteinuria","volume":"34","author":"Christopher-Stine","year":"2007","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.006_bib47","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5414\/CN107094","article-title":"The value of early renal biopsy in systemic lupus erythematosus patients presenting with renal involvement","volume":"77","author":"Hsieh","year":"2012","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.jaut.2016.06.006_bib48","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2014-000018","article-title":"Role of early repeated renal biopsies in lupus nephritis","volume":"1","author":"Zickert","year":"2014","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/j.jaut.2016.06.006_bib49","doi-asserted-by":"crossref","first-page":"138","DOI":"10.2215\/CJN.03400412","article-title":"Lupus nephritis: is the kidney biopsy currently necessary in the management of lupus nephritis?","volume":"8","author":"Giannico","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jaut.2016.06.006_bib50","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1136\/annrheumdis-2012-201940","article-title":"Joint european league against rheumatism and european renal association-european dialysis and transplant association (EULAR\/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis","volume":"71","author":"Bertsias","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.06.006_bib51","first-page":"1563","article-title":"Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure","volume":"33","author":"Faurschou","year":"2006","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.006_bib52","first-page":"2046","article-title":"The benefit of early treatment with immunosuppressive agents in lupus nephritis","volume":"21","author":"Esdaile","year":"1994","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.006_bib53","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1053\/ajkd.2002.36875","article-title":"SLE and idiopathic nephrotic syndrome: coincidence or not?","volume":"40","author":"Hertig","year":"2002","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jaut.2016.06.006_bib54","doi-asserted-by":"crossref","first-page":"120","DOI":"10.5414\/CNP57120","article-title":"Minimal change disease in systemic lupus erythematosus","volume":"57","author":"Dube","year":"2002","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.jaut.2016.06.006_bib55","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2215\/CJN.06720615","article-title":"Clinical-morphological features and outcomes of lupus podocytopathy","volume":"11","author":"Hu","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jaut.2016.06.006_bib56","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1681\/ASN.2004050350","article-title":"Glomerular podocytopathy in patients with systemic lupus erythematosus","volume":"16","author":"Kraft","year":"2005","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.jaut.2016.06.006_bib57","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1191\/0961203306lu2264oa","article-title":"Association of glomerular podocytopathy and nephrotic proteinuria in mesangial lupus nephritis","volume":"15","author":"Han","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.006_bib58","doi-asserted-by":"crossref","first-page":"914","DOI":"10.2215\/CJN.11751111","article-title":"Collapsing glomerulopathy in 19 patients with systemic lupus erythematosus or lupus-like disease","volume":"7","author":"Salvatore","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jaut.2016.06.006_bib59","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1053\/hupa.2001.28227","article-title":"Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature","volume":"32","author":"Baranowska-Daca","year":"2001","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.jaut.2016.06.006_bib60","first-page":"5","article-title":"IgA nephropathy: a rare lesion in systemic lupus erythematosus","volume":"8","author":"Mac-Moune Lai","year":"1995","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.jaut.2016.06.006_bib61","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1007\/s00296-011-2055-z","article-title":"Systemic lupus erythematosus associated with ANCA-associated vasculitis: an overlapping syndrome?","volume":"32","author":"Hervier","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2016.06.006_bib62","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1001\/archinte.1980.00330220073026","article-title":"Membranous lupus nephropathy initially seen as idiopathic membranous nephropathy. Possible diagnostic value of tubular reticular structures","volume":"140","author":"Shearn","year":"1980","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jaut.2016.06.006_bib63","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/ki.1983.170","article-title":"Pathologic differentiation between lupus and nonlupus membranous glomerulopathy","volume":"24","author":"Jennette","year":"1983","journal-title":"Kidney Int."},{"key":"10.1016\/j.jaut.2016.06.006_bib64","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.006_bib65","doi-asserted-by":"crossref","first-page":"436","DOI":"10.5414\/CNP69436","article-title":"Predominant tubulointerstitial nephritis in a patient with systemic lupus erythematosus: phenotype of infiltrating cells","volume":"69","author":"Omokawa","year":"2008","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.jaut.2016.06.006_bib66","doi-asserted-by":"crossref","first-page":"528","DOI":"10.5527\/wjn.v4.i5.528","article-title":"Lupus-associated thrombotic thrombocytopenic purpura-like microangiopathy","volume":"4","author":"Blum","year":"2015","journal-title":"World J. Nephrol."},{"key":"10.1016\/j.jaut.2016.06.006_bib67","first-page":"503","article-title":"Thrombotic microangiopathy and poor renal outcome in lupus patients with or without antiphospholipid syndrome","volume":"33","author":"Hernandez-Molina","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.006_bib68","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1523-1755.2001.00492.x","article-title":"Predictive power of the second renal biopsy in lupus nephritis: significance of macrophages","volume":"59","author":"Hill","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.jaut.2016.06.006_bib69","first-page":"693","article-title":"Repeated renal biopsy in proliferative lupus nephritis\u2013predictive role of serum C1q and albuminuria","volume":"29","author":"Gunnarsson","year":"2002","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.006_bib70","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00467-007-0447-9","article-title":"Outcomes of children with proliferative lupus nephritis: the role of protocol renal biopsy","volume":"22","author":"Askenazi","year":"2007","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.jaut.2016.06.006_bib71","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1177\/0961203313518625","article-title":"The value of repeat kidney biopsy in quiescent Argentinian lupus nephritis patients","volume":"23","author":"Alvarado","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.006_bib72","doi-asserted-by":"crossref","first-page":"801","DOI":"10.4103\/1319-2442.135016","article-title":"Protocol renal biopsy in patients with lupus nephritis: a single center experience","volume":"25","author":"Singh","year":"2014","journal-title":"Saudi J. Kidney Dis. Transpl."},{"key":"10.1016\/j.jaut.2016.06.006_bib73","article-title":"Histologic versus clinical remission in proliferative lupus nephritis","author":"Malvar","year":"2015","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.jaut.2016.06.006_bib74","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0049-0172(05)80019-8","article-title":"The pathogenesis and prognosis of lupus nephritis: information from repeat renal biopsy","volume":"23","author":"Esdaile","year":"1993","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.006_bib75","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/ndt\/gfr517","article-title":"Strategy for second kidney biopsy in patients with lupus nephritis","volume":"27","author":"Alsuwaida","year":"2012","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.jaut.2016.06.006_bib76","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1093\/ndt\/gfr553","article-title":"Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis Trial","volume":"27","author":"Stoenoiu","year":"2012","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.jaut.2016.06.006_bib77","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/art.22449","article-title":"Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis","volume":"56","author":"Grootscholten","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.006_bib78","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0272-6386(99)70082-X","article-title":"Clinical and prognostic value of serial renal biopsies in lupus nephritis","volume":"34","author":"Moroni","year":"1999","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jaut.2016.06.006_bib79","first-page":"2822","article-title":"Serial renal biopsy in systemic lupus erythematosus","volume":"27","author":"Bajaj","year":"2000","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.006_bib80","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1093\/ndt\/gfp359","article-title":"The clinical relevance of a repeat biopsy in lupus nephritis flares","volume":"24","author":"Daleboudt","year":"2009","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.jaut.2016.06.006_bib81","first-page":"2890","article-title":"Changes in pathological pattern and treatment regimens based on repeat renal biopsy in lupus nephritis","volume":"125","author":"Wang","year":"2012","journal-title":"Chin. Med. J. Engl."},{"key":"10.1016\/j.jaut.2016.06.006_bib82","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2013-000004","article-title":"Value of repeat biopsy in lupus nephritis flares","volume":"1","author":"Greloni","year":"2014","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/j.jaut.2016.06.006_bib83","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1093\/ndt\/gft272","article-title":"The value of repeat biopsy in the management of lupus nephritis: an international multicentre study in a large cohort of patients","volume":"28","author":"Pagni","year":"2013","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.jaut.2016.06.006_bib84","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000330356","article-title":"Repeat renal biopsy in lupus nephritis: a change in histological pattern is common","volume":"34","author":"Lu","year":"2011","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.jaut.2016.06.006_bib85","series-title":"Oxford Textbook of Clinical Nephrology, III edition","first-page":"156","article-title":"Renal biopsy-Procedure and complications","author":"Ponticelli","year":"2005"},{"key":"10.1016\/j.jaut.2016.06.006_bib86","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1038\/ki.1996.528","article-title":"Nephritic flares\u201d are predictors of bad long-term renal outcome in lupus nephritis","volume":"50","author":"Moroni","year":"1996","journal-title":"Kidney Int."},{"key":"10.1016\/j.jaut.2016.06.006_bib87","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1523-1755.2000.00832.x","article-title":"Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide","volume":"57","author":"Ioannidis","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.jaut.2016.06.006_bib88","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2215\/CJN.03280807","article-title":"Value of a complete or partial remission in severe lupus nephritis","volume":"3","author":"Chen","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jaut.2016.06.006_bib89","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1093\/ndt\/gfr741","article-title":"Complete remission in severe lupus nephritis: assessing the rate of loss in proteinuria","volume":"27","author":"Korbet","year":"2012","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.jaut.2016.06.006_bib90","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJM198603063141004","article-title":"Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs","volume":"314","author":"Austin","year":"1986","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jaut.2016.06.006_bib91","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/0140-6736(92)92292-N","article-title":"Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis","volume":"340","author":"Boumpas","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2016.06.006_bib92","doi-asserted-by":"crossref","first-page":"549","DOI":"10.7326\/0003-4819-125-7-199610010-00003","article-title":"Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial","volume":"125","author":"Gourley","year":"1996","journal-title":"Ann. Intern Med."},{"key":"10.1016\/j.jaut.2016.06.006_bib93","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/art.10142","article-title":"Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies","volume":"46","author":"Illei","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.006_bib94","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/096120339100100106","article-title":"Short course of weekly low-dose intravenous pulse cyclophosphamide in the treatment of lupus nephritis : a preliminary study","volume":"1","author":"Houssiau","year":"1991","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.006_bib95","article-title":"Immunosuppressive therapy in lupus nephritis: five year follow-up","volume":"37","author":"Cuadrado","year":"1994","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.006_bib96","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/art.10461","article-title":"Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide","volume":"46","author":"Houssiau","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.006_bib97","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/ard.2008.102533","article-title":"The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide","volume":"69","author":"Houssiau","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.06.006_bib98","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/ard.2002.003574","article-title":"EULAR randomized controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis","volume":"63","author":"Yee","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.06.006_bib99","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1053\/ajkd.2001.26084","article-title":"Treatment of diffuse proliferative lupus glomerulonephritis: a comparison of two cyclophosphamide-containing regimens","volume":"38","author":"Mok","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jaut.2016.06.006_bib100","first-page":"16","article-title":"Treatment of diffuse proliferative lupus nephritis by intravenous high-dose methylprednisolone","volume":"51","author":"Ponticelli","year":"1982","journal-title":"Q.\u00a0J. Med."},{"key":"10.1016\/j.jaut.2016.06.006_bib101","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1093\/ndt\/gfm245","article-title":"The long-term outcome of 93 patients with proliferative lupus nephritis","volume":"22","author":"Moroni","year":"2007","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.jaut.2016.06.006_bib102","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJM200010193431604","article-title":"Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis","volume":"343","author":"Chan","year":"2000","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jaut.2016.06.006_bib103","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1440-1797.2005.00444.x","article-title":"Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis","volume":"10","author":"Ong","year":"2005","journal-title":"Nephrol. Carlt."},{"key":"10.1016\/j.jaut.2016.06.006_bib104","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa043731","article-title":"Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis","volume":"353","author":"Ginzler","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"Suppl.\u00a0II","key":"10.1016\/j.jaut.2016.06.006_bib105","first-page":"349","article-title":"Mycophenolate mofetil or intravenous cyclophosphamide in treatment of lupus nephritis in Egyptian patients","volume":"67","author":"Mullic-Bacic","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.06.006_bib106","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s10157-010-0270-7","article-title":"Is mycophenolate mofetil superior to pulse intravenous cyclophosphamide for induction therapy of proliferative lupus nephritis in Egyptian patients?","volume":"14","author":"El-Shafey","year":"2010","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.jaut.2016.06.006_bib107","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1681\/ASN.2008101028","article-title":"Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis","volume":"20","author":"Appel","year":"2009","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.jaut.2016.06.006_bib108","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1053\/j.ajkd.2012.08.041","article-title":"Induction and maintenance treatment of proliferative lupus nephritis: a meta-analysis of randomized controlled trials","volume":"61","author":"Henderson","year":"2013","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jaut.2016.06.006_bib109","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/acr.21664","article-title":"American College of Rheumatology guidelines for screening, treatment and management of lupus nephritis","volume":"64","author":"Hahn","year":"2012","journal-title":"Arthritis Care Res. Hob."},{"key":"10.1016\/j.jaut.2016.06.006_bib110","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1136\/ard.2010.131995","article-title":"Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial","volume":"69","author":"Houssiau","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.06.006_bib111","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1056\/NEJMoa1014460","article-title":"Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis","volume":"365","author":"Dooley","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jaut.2016.06.006_bib112","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/rheumatology\/ket429","article-title":"Maintenance therapy of lupus nephritis with mycophenolate or azathioprine: systematic review and meta-analysis","volume":"53","author":"Maneiro","year":"2014","journal-title":"Rheumatol. Oxf."},{"key":"10.1016\/j.jaut.2016.06.006_bib113","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.3892\/etm.2014.1669","article-title":"Calcineurin inhibitors may be a reasonable alternative to cyclophosphamide in the induction treatment of active lupus nephritis: a systematic review and meta-analysis","volume":"7","author":"Yang","year":"2014","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.jaut.2016.06.006_bib114","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7326\/M14-1030","article-title":"Multitarget therapy for induction treatment of lupus nephritis: a randomized trial","volume":"162","author":"Liu","year":"2015","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jaut.2016.06.006_bib115","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2215\/CJN.02271205","article-title":"A\u00a0randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years","volume":"1","author":"Moroni","year":"2006","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jaut.2016.06.006_bib116","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/art.34359","article-title":"Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the lupus nephritis assessment with Rituximab study","volume":"64","author":"Rovin","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.006_bib117","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1177\/0961203313483376","article-title":"Rituximab in the treatment of resistant lupus nephritis: therapy failure in rapidly progressive crescentic lupus nephritis","volume":"22","author":"Davies","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.006_bib118","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1093\/rheumatology\/ket462","article-title":"Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study","volume":"53","author":"Moroni","year":"2014","journal-title":"Rheumatol. Oxf."},{"key":"10.1016\/j.jaut.2016.06.006_bib119","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1681\/ASN.2008060665","article-title":"Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy","volume":"20","author":"Austin","year":"2009","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.jaut.2016.06.006_bib120","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2310\/JIM.0b013e318204c965","article-title":"Systematic review and meta-analysis of immunosuppressant therapy clinical trials in membranous lupus nephritis","volume":"59","author":"Swan","year":"2011","journal-title":"J.\u00a0Investig. Med."},{"key":"10.1016\/j.jaut.2016.06.006_bib121","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ki.2009.412","article-title":"Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis","volume":"77","author":"Radhakrishnan","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.jaut.2016.06.006_bib122","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/0961203312465781","article-title":"Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE","volume":"22","author":"Dooley","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.006_bib123","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.autrev.2014.08.020","article-title":"The efficacy of novel B cell biologics as the future of SLE treatment: a review","volume":"13","author":"Kamal","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2016.06.006_bib124","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/art.1780341010","article-title":"Kidney biopsy in systemic lupus erythematosus. II. Survival analyses according to biopsy results","volume":"34","author":"McLaughlin","year":"1991","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.006_bib125","first-page":"692","article-title":"Correlation among WHO classes, histomorphologic patterns of glomerulonephritis and glomerular immune deposits in SLE","volume":"112","author":"Ferluga","year":"2000","journal-title":"Wien Klin. Wochenschr"},{"key":"10.1016\/j.jaut.2016.06.006_bib126","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/art.1780330708","article-title":"Contribution of renal biopsy data in predicting outcome in lupus nephritis. Analysis of 116 patients","volume":"33","author":"Nossent","year":"1990","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.006_bib127","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1191\/096120398678920730","article-title":"Renal biopsy in lupus nephritis","volume":"7","author":"Grande","year":"1998","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.006_bib128","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/ki.1994.70","article-title":"Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data","volume":"45","author":"Austin","year":"1994","journal-title":"Kidney Int."},{"key":"10.1016\/j.jaut.2016.06.006_bib129","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1177\/0961203313492576","article-title":"Progressive improvement of patient and renal survival and reduction of morbidity over time in patients with lupus nephritis (LN) followed for 20 years","volume":"22","author":"Moroni","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.006_bib130","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1177\/0961203309358901","article-title":"Isolated pyuria in systemic lupus erythematosus","volume":"19","author":"Appenzeller","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.006_bib131","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3899\/jrheum.140415","article-title":"Isolated hematuria and sterile pyuria may indicate systemic lupus erythematosus activity","volume":"42","author":"Ding","year":"2015","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.006_bib132","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1191\/096120301678646164","article-title":"Significance of isolated hematuria and isolated pyuria in systemic lupus erythematosus","volume":"10","author":"Rahman","year":"2001","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.jaut.2016.06.006_bib133","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1586\/1744666X.2015.990883","article-title":"The multifaceted aspects of refractory lupus nephritis","volume":"11","author":"Moroni","year":"2015","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.jaut.2016.06.006_bib134","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1093\/ndt\/gft343","article-title":"Rare transformation in repeat renal biopsies suggests a different pathogenesis of segmental and global lesions in proliferative lupus nephritis","volume":"28","author":"Tesar","year":"2013","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.jaut.2016.06.006_bib135","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s00296-011-1899-6","article-title":"Characteristics and influence factors of pathologic transformation in the subclasses of class IV lupus nephritis","volume":"32","author":"Gao","year":"2012","journal-title":"Rheumatol. Int."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841116300841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841116300841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:15:18Z","timestamp":1760256918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841116300841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":135,"alternative-id":["S0896841116300841"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2016.06.006","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lupus nephritis: When and how often to biopsy and what does it mean?","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2016.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}